1. Home
  2. ECF vs ENLV Comparison

ECF vs ENLV Comparison

Compare ECF & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

N/A

Current Price

$12.15

Market Cap

176.2M

Sector

Finance

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

N/A

Current Price

$0.73

Market Cap

149.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ECF
ENLV
Founded
1986
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.2M
149.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ECF
ENLV
Price
$12.15
$0.73
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
23.1K
249.3K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
6.42%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.71
$0.43
52 Week High
$13.85
$7.64

Technical Indicators

Market Signals
Indicator
ECF
ENLV
Relative Strength Index (RSI) 40.55 27.18
Support Level $12.15 $0.72
Resistance Level $12.32 $0.94
Average True Range (ATR) 0.16 0.13
MACD -0.01 0.01
Stochastic Oscillator 28.77 2.51

Price Performance

Historical Comparison
ECF
ENLV

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: